DK0744891T3 - Transgene fibrinogener - Google Patents

Transgene fibrinogener

Info

Publication number
DK0744891T3
DK0744891T3 DK95911012T DK95911012T DK0744891T3 DK 0744891 T3 DK0744891 T3 DK 0744891T3 DK 95911012 T DK95911012 T DK 95911012T DK 95911012 T DK95911012 T DK 95911012T DK 0744891 T3 DK0744891 T3 DK 0744891T3
Authority
DK
Denmark
Prior art keywords
fibrinogens
animals
modified
transgenic
human
Prior art date
Application number
DK95911012T
Other languages
English (en)
Inventor
William H Velander
William N Drohan
Henryk Lubon
Susan T Lord
John L Johnson
Christopher G Russell
Original Assignee
American Nat Red Cross
Virginia Tech Intell Prop
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Nat Red Cross, Virginia Tech Intell Prop, Univ North Carolina filed Critical American Nat Red Cross
Application granted granted Critical
Publication of DK0744891T3 publication Critical patent/DK0744891T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027New or modified breeds of vertebrates
    • A01K67/0275Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278Knock-in vertebrates, e.g. humanised vertebrates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745Blood coagulation or fibrinolysis factors
    • C07K14/75Fibrinogen
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00Modified animals
    • A01K2207/15Humanized animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00Genetically modified animals
    • A01K2217/05Animals comprising random inserted nucleic acids (transgenic)
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/105Murine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00Animals characterised by species
    • A01K2227/10Mammal
    • A01K2227/108Swine
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01KANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00Animals characterised by purpose
    • A01K2267/01Animal expressing industrially exogenous proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK95911012T 1994-02-18 1995-02-17 Transgene fibrinogener DK0744891T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19806894A 1994-02-18 1994-02-18
PCT/US1995/001944 WO1995022249A1 (en) 1994-02-18 1995-02-17 Transgenic fibrinogen

Publications (1)

Publication Number Publication Date
DK0744891T3 true DK0744891T3 (da) 2008-02-04

Family

ID=22731871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95911012T DK0744891T3 (da) 1994-02-18 1995-02-17 Transgene fibrinogener

Country Status (9)

Country Link
EP (1) EP0744891B1 (da)
JP (1) JPH10500003A (da)
AT (1) ATE374525T1 (da)
CA (1) CA2183546C (da)
DE (1) DE69535604T2 (da)
DK (1) DK0744891T3 (da)
ES (1) ES2296289T3 (da)
PT (1) PT744891E (da)
WO (1) WO1995022249A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998035689A1 (en) * 1997-02-14 1998-08-20 American Red Cross Expression of active human factor ix in mammary tissue of transgenic animals
US6933366B2 (en) 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US20020184655A1 (en) * 1997-12-01 2002-12-05 Henryk Lubon Methods for the degradation and detoxification of organic material using urine produced by transgenic animals and related transgenic animals and proteins
JP2002525047A (ja) * 1998-09-16 2002-08-13 ネクシア バイオテクノロジーズ, インコーポレイテッド 尿における組換え蛋白質の産生
AU6104799A (en) * 1998-09-24 2000-04-10 Ppl Therapeutics (Scotland) Limited Purification of fibrinogen from fluids by precipitation and hydrophoic chromatography
US7030289B2 (en) 1998-11-19 2006-04-18 Ppl Therapeutics (Scotland) Ltd Stabilization of milk from transgenic animals
GB9825374D0 (en) * 1998-11-19 1999-01-13 Ppl Therapeutics Scotland Ltd Method
NZ511299A (en) * 1998-11-19 2003-02-28 Ppl Therapeutics Scotland Ltd Stabilisation of milk from transgenic animals through expression of a serine proteinase inhibitor and optionally fibrinogen in the mammary gland
JP2004509621A (ja) * 2000-09-19 2004-04-02 トリペップ アクチ ボラゲット 病原体上の受容体に対して抗体を再指向させるリガンド/受容体特異性変換体
KR20050099536A (ko) 2003-02-06 2005-10-13 트리펩 아베 글리코실화된 특이성 교환체
US7335359B2 (en) 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
US8283137B2 (en) 2003-07-29 2012-10-09 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Process for producing recombinant fibrinogen highly producing cell and highly producing cell
EP3225252A1 (en) 2008-05-02 2017-10-04 Laboratoire Français du Fractionnement et des Biotechnologies Treatment of bleeding with low half-life fibrinogen
US9433700B2 (en) 2009-04-27 2016-09-06 Medibeacon Inc. Tissue sealant compositions, vascular closure devices, and uses thereof
US9546381B2 (en) 2010-03-17 2017-01-17 Pharming Intellectual Property Bv Use of anticoagulants in the production of recombinant proteins in the milk of transgenic animals
JP5839810B2 (ja) * 2011-03-03 2016-01-06 日本製粉株式会社 フィブリノゲンを産生するトランスジェニックカイコ
EP2556842A1 (en) 2011-08-11 2013-02-13 Bioftalmik, S.L. Composition in the form of film comprising fibrinogen and a fibrinogen activator and the applications thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE211177T1 (de) * 1991-01-11 2002-01-15 American Nat Red Cross Expression von aktivem menschlichem protein c im milchdrüsengewebe transgener tiere

Also Published As

Publication number Publication date
CA2183546A1 (en) 1995-08-24
EP0744891B1 (en) 2007-10-03
WO1995022249A1 (en) 1995-08-24
DE69535604T2 (de) 2008-05-21
DE69535604D1 (en) 2007-11-15
JPH10500003A (ja) 1998-01-06
EP0744891A1 (en) 1996-12-04
ATE374525T1 (de) 2007-10-15
ES2296289T3 (es) 2008-04-16
CA2183546C (en) 2001-08-21
PT744891E (pt) 2008-01-14

Similar Documents

Publication Publication Date Title
ATE374525T1 (de) Transgenes fibrinogen
EP0737746A3 (en) Production of recombinant polypeptides by bovine species and transgenic methods
DE69534295D1 (de) Fibrinogenproduktion in transgenen tieren
ATE391181T1 (de) Bioaktive il-12 fusionsproteine
DE3382760D1 (de) Herstellung von funktionellen menschlichen Urokinasepolypeptiden.
ATE128625T1 (de) Expression von proteinen in milch.
ATE159289T1 (de) Herstellung von peptiden
NZ521396A (en) Fusion proteins comprising two or more Neisseria polypeptides
DK1218504T3 (da) GL50 molekyler og anvendelser deraf
WO1996034966A3 (en) Engineering protein posttranslational modification in transgenic organisms
DK0555435T3 (da) DNA-sekvens, der koder bovint alfa-lactalbumin, og fremgangsmåder til anvendelse
DK175989A (da) Fremgangsmaade til fremstilling af protein
WO2001019846A8 (en) Transgenically produced fusion proteins
IL115873A0 (en) Transgenic protein production
EP1147184A4 (en) REGULATED EXPRESSION OF HETEROLOGOUS PROTEINS IN THE MAMMARY GLAND OF A TRANSGENIC ANIMAL
ATE36348T1 (de) Herstellungsverfahren und selektive isolierung von proteinen und polypeptiden, rekombinant und expressionsvektor dazu und schmelzprotein das zum konstanten teil von immoglobulinen binden kann.